Fayetteville Firm Receives $1.5M to Further Develop Brain Injury Diagnostics

by Mark Carter  on Thursday, Jan. 9, 2014 2:16 pm  

The Phase I prototype of SFC Fluidics' MD Analyzer™ diagnostic platform. The Phase II grant will fund its further development. (Courtesy of SFC Fluidics)

Fayetteville's SFC Fluidics has received a $1.5 million federal grant to further develop its MD Analyzer diagnostic platform, the company announced Thursday.

The platform monitors patients suffering from severe traumatic brain injury, providing diagnostic readouts every 10 minutes of biochemicals released by injured brains.

The Phase II research grant from the National Institutes of Health will fund advanced development of the platform, the company said.

SFC Fluidics is a portfolio company of Fayetteville's VIC Technology Venture Development and a client firm of Innovate Arkansas and the Arkansas Science & Technology Authority.

The company also is developing diagnostic instruments to improve the diagnosis and monitoring of brain injury patients including a 10-minute pinprick blood test for triage patients, according to a company news release. Its product lines include point-of-care diagnostics, analytical instrumentation and drug delivery.

The MS Analyzer platform will enable doctors to "closely and accurately track the progress of patients, respond rapidly to any changes, and improve short- and long-term clinical outcomes," the release said.

Recently, SFC Fluidics completed a $1 million funding round from a private investor.



Please read our comments policy before commenting.